![](https://investorshub.advfn.com/uicon/358623.png?cb=1554503635)
Wednesday, February 21, 2024 6:59:31 AM
Keep an eye on Twitter too
Recent AMLX News
- Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm • PR Newswire (US) • 07/18/2024 11:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 11:09:00 AM
- Amylyx Pharmaceuticals Announces Acquisition of Phase 3-ready GLP-1 Receptor Antagonist (Avexitide) with FDA Breakthrough Therapy Designation • Business Wire • 07/10/2024 11:00:00 AM
- Amylyx Pharmaceuticals to Host Conference Call to Discuss the Acquisition of Avexitide • Business Wire • 07/09/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:52:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:50:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:49:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:07:30 PM
- Amylyx Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference • Business Wire • 06/04/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 11:36:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 11:12:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:05:38 AM
- Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results • Business Wire • 05/09/2024 11:00:00 AM
- Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference • Business Wire • 05/08/2024 01:00:00 PM
- Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024 • Business Wire • 05/02/2024 01:00:00 PM
- Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome • Business Wire • 04/10/2024 01:00:00 PM
- The Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AMLX • PR Newswire (US) • 04/09/2024 09:45:00 AM
- Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024 • Business Wire • 04/08/2024 01:00:00 PM
- Amylyx Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - AMLX • PR Newswire (US) • 04/05/2024 09:45:00 AM
- Amylyx Pharmaceuticals Announces Formal Intention to Remove RELYVRIO®/ALBRIOZA™ from the Market; Provides Updates on Access to Therapy, Pipeline, Corporate Restructuring, and Strategy • Business Wire • 04/04/2024 11:00:00 AM
- The Gross Law Firm Reminds Amylyx Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 9, 2024 - AMLX • PR Newswire (US) • 04/02/2024 09:45:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Amylyx Pharmaceuticals, Inc.(AMLX) Shareholders • PR Newswire (US) • 03/29/2024 09:45:00 AM
- Shareholders of Amylyx Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before April 9, 2024 to Discuss Your Rights - AMLX • PR Newswire (US) • 03/26/2024 09:45:00 AM
- AMLX) INVESTORS WITH LOSSES OF MORE THAN $100,000 ENCOURAGED TO SEEK APPOINTMENT AS LEAD PLAINTIFF - April 9, 2024 DEADLINE • PR Newswire (US) • 03/25/2024 12:00:00 PM
- The Gross Law Firm Notifies Shareholders of Amylyx Pharmaceuticals, Inc.(AMLX) of a Class Action Lawsuit and an Upcoming Deadline • PR Newswire (US) • 03/22/2024 09:45:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM